Skip to content

Medicaid Tries New Approach With Sickle Cell: Companies Get Paid Only if Costly Gene Therapies Work

The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With more expensive treatments on the horizon, the program — created by the Biden administration and continued under President Trump — could help Medicaid save money and treat more patients.

GOP Promotes MAHA Agenda in Bid To Avert Midterm Losses. Dems Point to Contradictions.

As fractures emerge in the Make America Great Again movement, some Republicans see its health-focused "MAHA" counterpart as the party’s next big thing. But doubts abound.

Listen to the Latest ‘KFF Health News Minute’

The "KFF Health News Minute” brings original health care and health policy reporting from our newsroom to the airwaves each week.

Letters to the Editor

Readers Balk at ‘Gold Standard’ of Autism Treatment

KFF Health News gives readers a chance to comment on a recent batch of stories.

As Insurance Prices Rise, Families Puzzle Over Options

Millions of middle-class Americans who have Affordable Care Act marketplace plans are facing soaring premium payments in 2026. Some people are contemplating big life changes to deal with new rates that kicked in on Jan. 1.

Weekly Podcast

What the Health? From KFF Health News: Culture Wars Take Center Stage

Daily Cartoon

‘I Believe?’

Used with the permission of Bob and Tom Thaves. Cartoons are the property of their respective artists and are subject to copyright laws. Do not reproduce or redistribute this cartoon without permission of the artist.

View All Cartoons